FDA hands Cassiopea its first approval, for acne drug Winlevi
pharmaphorum
AUGUST 28, 2020
Shares in dermatology specialist Cassiopea, which is listed on the SWX exchange in Switzerland, rose almost 17% after news of the FDA approval emerged. The post FDA hands Cassiopea its first approval, for acne drug Winlevi appeared first on. Cassiopea spun out of Ireland-domiciled Cosmo Pharma in 2015.
Let's personalize your content